Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anja W. Olsen"'
Autor:
Ida Rosenkrands, Anja W. Olsen, Sara Knudsen, Nida Dehari, Helene Bæk Juel, Hannah M. Cheeseman, Peter Andersen, Robin J. Shattock, Frank Follmann
Publikováno v:
EBioMedicine, Vol 104, Iss , Pp 105140- (2024)
Summary: Background: Chlamydia trachomatis (CT) Major Outer Membrane Protein (MOMP) holds a neutralising epitope in the Variable Domain 4 (VD4), and this region’s immune dominance during infection is well known. This study aimed to assess the antib
Externí odkaz:
https://doaj.org/article/56f3ce12fe2f407d8fceb4d157c98d9d
Autor:
Anja W. Olsen, Ida Rosenkrands, Christina S. Jacobsen, Hannah M. Cheeseman, Max P. Kristiansen, Jes Dietrich, Robin J. Shattock, Frank Follmann
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract The clinical development of an effective Chlamydia vaccine requires in-depth understanding of how well protective pre-clinical immune signatures translate to humans. Here, we report a comparative immunological characterization of CTH522/CAF
Externí odkaz:
https://doaj.org/article/2c0e390bee2742f3b8d0b209bed52afb
Autor:
Emma Lorenzen, Vanessa Contreras, Anja W. Olsen, Peter Andersen, Delphine Desjardins, Ida Rosenkrands, Helene Bæk Juel, Benoit Delache, Sebastien Langlois, Constance Delaugerre, Christophe Joubert, Nathalie Dereuddre-Bosquet, Cécile Bébéar, Bertille De Barbeyrac, Arabella Touati, Paul F. McKay, Robin J. Shattock, Roger Le Grand, Frank Follmann, Jes Dietrich
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
It is of international priority to develop a vaccine against sexually transmitted Chlamydia trachomatis infections to combat the continued global spread of the infection. The optimal immunization strategy still remains to be fully elucidated. The aim
Externí odkaz:
https://doaj.org/article/8eba49251cfe46ee8889846d67ba7fb9
Autor:
Eleanor L, Watts, Aurora, Perez-Cornago, Georgina K, Fensom, Karl, Smith-Byrne, Urwah, Noor, Colm D, Andrews, Marc J, Gunter, Michael V, Holmes, Richard M, Martin, Konstantinos K, Tsilidis, Demetrius, Albanes, Aurelio, Barricarte, Bas, Bueno-de-Mesquita, Chu, Chen, Barbara A, Cohn, Niki L, Dimou, Luigi, Ferrucci, Leon, Flicker, Neal D, Freedman, Graham G, Giles, Edward L, Giovannucci, Gary E, Goodman, Christopher A, Haiman, Graeme J, Hankey, Jiaqi, Huang, Wen-Yi, Huang, Lauren M, Hurwitz, Rudolf, Kaaks, Paul, Knekt, Tatsuhiko, Kubo, Hilde, Langseth, Gail, Laughlin, Loic, Le Marchand, Tapio, Luostarinen, Robert J, MacInnis, Hanna O, Mäenpää, Satu, Männistö, E Jeffrey, Metter, Kazuya, Mikami, Lorelei A, Mucci, Anja W, Olsen, Kotaro, Ozasa, Domenico, Palli, Kathryn L, Penney, Elizabeth A, Platz, Harri, Rissanen, Norie, Sawada, Jeannette M, Schenk, Pär, Stattin, Akiko, Tamakoshi, Elin, Thysell, Chiaojung Jillian, Tsai, Shoichiro, Tsugane, Lars, Vatten, Elisabete, Weiderpass, Stephanie J, Weinstein, Lynne R, Wilkens, Bu B, Yeap, Naomi E, Allen, Timothy J, Key, Ruth C, Travis
Publikováno v:
Watts, E L, Martin, R M & the PRACTICAL Consortium 2022, ' Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia ', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046 . https://doi.org/10.1002/ijc.34116
International Journal of Cancer
Watts, E L, Perez-Cornago, A, Fensom, G K, Smith-Byrne, K, Noor, U, Andrews, C D, Gunter, M J, Holmes, M V, Martin, R M, Tsilidis, K K, Albanes, D, Barricarte, A, Bueno-de-Mesquita, H B, Chen, C, Cohn, B A, Dimou, N L, Ferrucci, L, Flicker, L, Freedman, N D, Giles, G G, Giovannucci, E L, Goodman, G E, Haiman, C A, Hankey, G J, Huang, J, Huang, W-Y, Hurwitz, L M, Kaaks, R, Knekt, P, Kubo, T, Langseth, H, Laughlin, G, Le Marchand, L, Luostarinen, T, MacInnis, R J, Mäenpää, H O, Männistö, S, Metter, E J, Mikami, K, Mucci, L A, Olsen, A W, Ozasa, K, Palli, D, Penney, K L, Platz, E A, Rissanen, H, Sawada, N, Schenk, J M, Stattin, P, PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS & Tamakoshi, A 2022, ' Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia ', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046 . https://doi.org/10.1002/ijc.34116
International Journal of Cancer
Watts, E L, Perez-Cornago, A, Fensom, G K, Smith-Byrne, K, Noor, U, Andrews, C D, Gunter, M J, Holmes, M V, Martin, R M, Tsilidis, K K, Albanes, D, Barricarte, A, Bueno-de-Mesquita, H B, Chen, C, Cohn, B A, Dimou, N L, Ferrucci, L, Flicker, L, Freedman, N D, Giles, G G, Giovannucci, E L, Goodman, G E, Haiman, C A, Hankey, G J, Huang, J, Huang, W-Y, Hurwitz, L M, Kaaks, R, Knekt, P, Kubo, T, Langseth, H, Laughlin, G, Le Marchand, L, Luostarinen, T, MacInnis, R J, Mäenpää, H O, Männistö, S, Metter, E J, Mikami, K, Mucci, L A, Olsen, A W, Ozasa, K, Palli, D, Penney, K L, Platz, E A, Rissanen, H, Sawada, N, Schenk, J M, Stattin, P, PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS & Tamakoshi, A 2022, ' Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia ', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046 . https://doi.org/10.1002/ijc.34116
Publisher Copyright: © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. Previous studies had limited power to assess the associations of testosterone with aggressive disease as a primary endpoin